Zimmer Biomet Holdings (XSWX:ZBH) Research & Development : CHF412 Mil (TTM As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Zimmer Biomet Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zimmer Biomet Holdings's Research & Development for the three months ended in Dec. 2023 was CHF98 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was CHF412 Mil.

Zimmer Biomet Holdings Research & Development Historical Data

The historical data trend for Zimmer Biomet Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Research & Development Chart

Zimmer Biomet Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

441.48

286.78

401.37

378.23

396.68

Zimmer Biomet Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial															100.61	102.18	106.34	105.16	97.98

Zimmer Biomet Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF412 Mil.

Zimmer Biomet Holdings (XSWX:ZBH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Zimmer Biomet Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (XSWX:ZBH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (XSWX:ZBH) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

ZBH:USA ZIM:Germany ZBH:Austria

Address

345 East Main Street, Warsaw, IN, USA, 46580

Website

https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.